Cargando…
PTHG2 Reduces Bone Loss in Ovariectomized Mice by Directing Bone Marrow Mesenchymal Stem Cell Fate
Teriparatide, also known as 1-34 parathyroid hormone (PTH (1-34)), is commonly used for the treatment of osteoporosis in postmenopausal women. But its therapeutic application is restricted by poor metabolic stability, low bioavailability, and rapid clearance. Herein, PTHG2, a glycosylated teriparati...
Autores principales: | Chen, Jiao, Zhang, Hao, Wu, Xianmin, Wang, Fuxiao, Wang, Yili, Gao, Qianmin, Liu, Han, Hu, Yan, Su, Jiacan, Jing, Yingying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720025/ https://www.ncbi.nlm.nih.gov/pubmed/34976071 http://dx.doi.org/10.1155/2021/8546739 |
Ejemplares similares
-
Bone Marrow Mesenchymal Stromal Cells: Identification, Classification, and Differentiation
por: Gao, Qianmin, et al.
Publicado: (2022) -
Loss of Bcl-3 delays bone fracture healing through activating NF-κB signaling in mesenchymal stem cells
por: Wang, Fuxiao, et al.
Publicado: (2022) -
RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation
por: Chen, Xiao, et al.
Publicado: (2018) -
Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis
por: Chen, Xiao, et al.
Publicado: (2017) -
Correction to: RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation
por: Chen, Xiao, et al.
Publicado: (2022)